+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Sale

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120181
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Coronary Drug Eluting Stent Market is projected to reach USD 8.71 Billion in 2026. It is expected to continue growing at a CAGR of 5.51%, reaching USD 12.16 Billion by 2032.

Implantable Coronary Drug-Eluting Stents: Executive Overview

Implantable coronary drug-eluting stents are catheter-delivered devices designed to reopen narrowed coronary arteries while releasing an antiproliferative medicine to reduce tissue growth and the risk of restenosis. Their clinical role is shaped by evidence on safety, lesion suitability, delivery performance, dual-antiplatelet therapy, operator expertise, and access to follow-up care. Adoption therefore depends on more than device characteristics: diagnostic capacity, reimbursement, hospital infrastructure, and cardiovascular disease burden are also influential.

Clinical Practice Is Shifting Toward Precision and Lifetime Outcomes

The field is moving from a device-centered approach toward patient- and lesion-specific treatment planning. Intravascular imaging, physiological assessment, improved stent platforms, thinner struts, optimized polymer technologies, and better implantation techniques support more selective intervention and may help reduce complications. At the same time, clinical decisions increasingly weigh bleeding risk, ischemic risk, comorbidities, lesion complexity, and the possibility of shortening or tailoring antiplatelet treatment. Guideline updates and long-term comparative evidence remain important to determining how quickly these practices diffuse.

Artificial Intelligence Strengthens Diagnosis, Planning, and Follow-Up

Artificial intelligence is contributing to coronary care through image interpretation, lesion detection, risk stratification, procedural planning, and analysis of longitudinal patient records. In catheterization laboratories, algorithm-assisted interpretation may help identify anatomically or physiologically significant disease and support more consistent review of intravascular images. Post-procedure, predictive tools can assist with medication adherence, readmission risk, and follow-up prioritization. Effective deployment still requires representative validation data, clinician oversight, cybersecurity, interoperability, transparent performance monitoring, and safeguards against automation bias.

Regional Insights: Uneven Access Shapes Adoption and Outcomes

North America combines advanced interventional infrastructure, broad use of imaging, and established reimbursement pathways, while evidence-based utilization and cost scrutiny remain central. Europe benefits from mature cardiology networks, strong regulatory and guideline frameworks, and variation in reimbursement and waiting times across countries. Asia-Pacific includes highly developed systems such as Japan, Australia, and South Korea alongside rapidly expanding capacity in China and India; affordability, training, and rural access remain differentiators. Latin America continues to face disparities in public and private provision, with Brazil and Mexico serving as important reference markets. The Middle East shows concentrated investment in specialist hospitals and cardiac services, particularly in Gulf states, whereas Africa’s progress is constrained by limited catheterization capacity, workforce shortages, and uneven access to essential medicines and follow-up care.

Group Insights: Policy Alignment and Health-System Capacity Matter

ASEAN members show substantial variation in reimbursement, specialist availability, and public-sector capacity, making regional training and procurement coordination valuable. BRICS countries combine large and diverse patient populations with differing regulatory systems, infrastructure, and affordability constraints; domestic manufacturing and technology-transfer policies may influence access. The European Union benefits from cross-border scientific and regulatory cooperation, although national purchasing and reimbursement decisions remain distinct. G7 systems generally have strong clinical research and procedural infrastructure but face aging populations, budget pressure, and demands for demonstrable value. GCC countries are strengthening advanced cardiac services through centralized investment, while NATO members span highly mature systems and countries where resilience, procurement, and equitable access remain priorities.

Country Insights: Diverse Systems Require Tailored Implementation

Australia emphasizes evidence-based funding, specialist coordination, and access across dispersed communities. Brazil and Mexico must balance tertiary-care capability with geographic and socioeconomic disparities. Canada and the United States have sophisticated interventional networks, with access shaped by provincial or payer arrangements, hospital capacity, and prior authorization. China and India are expanding cardiovascular capability while addressing regional variation, affordability, and workforce distribution. France, Germany, Italy, Spain, and the United Kingdom operate within mature European frameworks but differ in procurement, waiting-list management, reimbursement, and service organization. Japan prioritizes careful clinical evaluation and an aging-patient perspective, while South Korea combines advanced hospitals with strong technology adoption. Russia’s landscape is influenced by domestic production, supply continuity, and uneven regional capacity.

Priorities for Leaders: Integrate Evidence, Access, and Digital Governance

Industry leaders should align product development with clearly defined clinical needs, including complex anatomy, bleeding-risk management, deliverability, imaging compatibility, and long-term safety. They should generate durable evidence across diverse populations, support physician training, and collaborate with hospitals on implantation quality and follow-up pathways. Access strategies should account for public procurement, health-technology assessment, affordability, and local service capacity rather than relying on a single commercial model. AI programs should begin with validated use cases, measurable clinical endpoints, human oversight, and robust data-governance controls. Continuous monitoring of adverse events, treatment adherence, and real-world outcomes can improve both patient safety and stakeholder confidence.

Research Methodology: Evidence-Led Assessment of the Stent Landscape

This executive summary uses a structured assessment of the implantable coronary drug-eluting stent field, focusing on clinical practice, enabling technologies, regulatory and reimbursement conditions, health-system infrastructure, and access constraints. The framework compares the required regions, country groups, and countries through secondary review of authoritative clinical guidance, peer-reviewed research, regulatory materials, public health statistics, procurement policies, and health-system publications. Findings are synthesized qualitatively to identify durable shifts, implementation barriers, and strategic priorities. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Sustainable Progress Depends on Better Patient Selection and Delivery

Implantable coronary drug-eluting stents remain an important tool in contemporary coronary intervention, but outcomes depend on appropriate selection, high-quality implantation, evidence-based antiplatelet management, and reliable follow-up. Regional and country differences in infrastructure, reimbursement, workforce, and affordability will continue to shape real-world benefit. The strongest path forward combines safer device design, precision diagnostics, responsible AI, clinician training, and health-system partnerships that extend effective care beyond major specialist centers.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Coronary Drug Eluting Stent Market, by Drug Type
7.1. Introduction
7.2. Everolimus Eluting
7.3. Paclitaxel Eluting
7.4. Sirolimus Eluting
7.5. Zotarolimus Eluting
8. Implantable Coronary Drug Eluting Stent Market, by Generation
8.1. Introduction
8.2. First Generation
8.3. Second Generation
8.4. Third Generation
9. Implantable Coronary Drug Eluting Stent Market, by Polymer Type
9.1. Introduction
9.2. Biodegradable Polymer
9.3. Durable Polymer
9.4. Polymer Free
10. Implantable Coronary Drug Eluting Stent Market, by Stent Material
10.1. Introduction
10.2. Cobalt Chromium
10.3. Platinum Chromium
10.4. Stainless Steel
11. Implantable Coronary Drug Eluting Stent Market, by Indication
11.1. Introduction
11.2. Multivessel Disease
11.3. Non St Elevation Myocardial Infarction
11.4. St Elevation Myocardial Infarction
11.5. Stable Angina
12. Implantable Coronary Drug Eluting Stent Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Implantable Coronary Drug Eluting Stent Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Implantable Coronary Drug Eluting Stent Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Alvimedica Medical Technologies Inc.
16.3. B. Braun Melsungen AG
16.4. Biosensors International Group, Ltd.
16.5. Biotronik SE & Co. KG
16.6. Boston Scientific Corporation
16.7. Concept Medical, Inc.
16.8. Cook Medical Incorporated
16.9. Hexacath S.A.S.
16.10. Lepu Medical Technology (Beijing) Co., Ltd.
16.11. Medinol Ltd.
16.12. Medtronic plc
16.13. Meril Life Sciences Pvt. Ltd.
16.14. MicroPort Scientific Corporation
16.15. OrbusNeich Medical Group
16.16. REVA Medical, Inc.
16.17. Sahajanand Medical Technologies Ltd.
16.18. SINOMED Co., Ltd.
16.19. Terumo Corporation
16.20. Translumina GmbH
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Implantable Coronary Drug Eluting Stent Market, Years Considered for the Study
FIGURE 2. Global Implantable Coronary Drug Eluting Stent Market, Research Design
FIGURE 3. Global Implantable Coronary Drug Eluting Stent Market, Research Framework
FIGURE 4. Global Implantable Coronary Drug Eluting Stent Market, Data Triangulation
FIGURE 5. Global Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2025 vs 2032 (%)
FIGURE 9. Global Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2025 vs 2032 (%)
FIGURE 11. Global Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2025 vs 2032 (%)
FIGURE 13. Global Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 15. Global Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Implantable Coronary Drug Eluting Stent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Implantable Coronary Drug Eluting Stent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Implantable Coronary Drug Eluting Stent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Implantable Coronary Drug Eluting Stent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Implantable Coronary Drug Eluting Stent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Implantable Coronary Drug Eluting Stent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Implantable Coronary Drug Eluting Stent Market Segmentation & Coverage
TABLE 2. Global Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global Everolimus Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Everolimus Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Everolimus Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Paclitaxel Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Paclitaxel Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Paclitaxel Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sirolimus Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sirolimus Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sirolimus Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Zotarolimus Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Zotarolimus Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Zotarolimus Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 17. Global First Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global First Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global First Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Second Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Second Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Second Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Third Generation Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Third Generation Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Third Generation Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 27. Global Biodegradable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Biodegradable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Biodegradable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Durable Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Durable Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Durable Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Polymer Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Polymer Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Polymer Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 37. Global Cobalt Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Cobalt Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Cobalt Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Platinum Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Platinum Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Platinum Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Stainless Steel Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Stainless Steel Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Stainless Steel Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 47. Global Multivessel Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Multivessel Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Multivessel Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Non St Elevation Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Non St Elevation Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Non St Elevation Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global St Elevation Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global St Elevation Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global St Elevation Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 66. North America Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 68. North America Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 69. North America Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 70. North America Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 71. North America Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 72. Latin America Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 74. Latin America Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 75. Latin America Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 76. Latin America Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 77. Latin America Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 78. Europe Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 80. Europe Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 81. Europe Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 82. Europe Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 83. Europe Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 84. Middle East Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Middle East Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 86. Middle East Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 87. Middle East Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 88. Middle East Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 89. Middle East Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 90. Africa Implantable Coronary Drug Eluting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Africa Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 92. Africa Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 93. Africa Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 94. Africa Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 95. Africa Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 96. Global Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 99. ASEAN Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 100. ASEAN Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 101. ASEAN Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 102. ASEAN Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. GCC Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. GCC Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 105. GCC Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 106. GCC Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 107. GCC Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 108. GCC Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 109. European Union Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. European Union Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 111. European Union Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 112. European Union Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 113. European Union Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 114. European Union Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 115. BRICS Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. BRICS Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 117. BRICS Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 118. BRICS Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 119. BRICS Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 120. BRICS Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 121. G7 Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. G7 Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 123. G7 Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 124. G7 Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 125. G7 Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 126. G7 Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 127. NATO Implantable Coronary Drug Eluting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. NATO Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 129. NATO Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 130. NATO Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 131. NATO Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 132. NATO Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 133. Global Implantable Coronary Drug Eluting Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. United States Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 135. United States Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 136. United States Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 137. United States Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 138. United States Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 139. United States Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 140. Canada Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 141. Canada Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 142. Canada Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 143. Canada Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 144. Canada Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 145. Canada Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 146. Mexico Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 147. Mexico Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 148. Mexico Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 149. Mexico Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 150. Mexico Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 151. Mexico Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. Brazil Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 153. Brazil Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 154. Brazil Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 155. Brazil Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 156. Brazil Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 157. Brazil Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 158. United Kingdom Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 159. United Kingdom Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 160. United Kingdom Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 161. United Kingdom Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 162. United Kingdom Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 163. United Kingdom Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 164. Germany Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 165. Germany Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 166. Germany Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 167. Germany Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 168. Germany Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 169. Germany Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 170. France Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 171. France Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 172. France Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 173. France Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 174. France Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 175. France Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 176. Russia Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 177. Russia Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 178. Russia Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 179. Russia Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 180. Russia Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 181. Russia Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 182. Italy Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 183. Italy Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 184. Italy Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 185. Italy Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 186. Italy Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 187. Italy Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 188. Spain Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 189. Spain Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 190. Spain Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 191. Spain Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 192. Spain Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 193. Spain Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 194. China Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 195. China Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 196. China Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 197. China Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 198. China Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 199. China Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 200. India Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 201. India Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 202. India Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 203. India Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 204. India Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 205. India Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 206. Japan Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 207. Japan Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 208. Japan Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 209. Japan Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 210. Japan Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 211. Japan Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 212. Australia Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 213. Australia Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 214. Australia Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 215. Australia Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 216. Australia Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 217. Australia Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 218. South Korea Implantable Coronary Drug Eluting Stent Market Size, 2017-2032 (USD Million)
TABLE 219. South Korea Implantable Coronary Drug Eluting Stent Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 220. South Korea Implantable Coronary Drug Eluting Stent Market Size, by Generation, 2017-2032 (USD Million)
TABLE 221. South Korea Implantable Coronary Drug Eluting Stent Market Size, by Polymer Type, 2017-2032 (USD Million)
TABLE 222. South Korea Implantable Coronary Drug Eluting Stent Market Size, by Stent Material, 2017-2032 (USD Million)
TABLE 223. South Korea Implantable Coronary Drug Eluting Stent Market Size, by Indication, 2017-2032 (USD Million)
TABLE 224. Global Implantable Coronary Drug Eluting Stent Market Share, by Key Player, 2025
TABLE 225. Global Implantable Coronary Drug Eluting Stent Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alvimedica Medical Technologies Inc.
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Concept Medical, Inc.
  • Cook Medical Incorporated
  • Hexacath S.A.S.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Group
  • REVA Medical, Inc.
  • Sahajanand Medical Technologies Ltd.
  • SINOMED Co., Ltd.
  • Terumo Corporation
  • Translumina GmbH

Related Topics

Related Reports

Implantable Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032 - Product Image

Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034? - Product Image

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034?

  • Report
  • 149 Pages
  • Global
From
Drug-Eluting Stents - Global Strategic Business Report - Product Image

Drug-Eluting Stents - Global Strategic Business Report

  • Report
  • 465 Pages
  • Global
From
Drug Eluting Stent Market Report 2026 - Product Image

Drug Eluting Stent Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.